Kathryn Lang

Kathryn Lang

Company: Guardant Health

Job title: Vice President, Outcomes and Evidence


10.15 | 7.15 Opportunities for Liquid Biopsy Across the Continuum of Care 10:15 am

With the successful clinical adoption of LBx in late stage cancer, attention is now turning to opportunities earlier in the patient journey Earlier stage cancers require integration of several biomarkers to deliver appropriate sensitivity Progress is being made to generate the evidence to support clinical adoption, but regulatory and reimbursement hurdles must also be overcomeRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.